HOPEMATIC Sdn Bhd is one of the subsidiaries of INS Bioscience Berhad, which is the first bioscience technology company listed on the Mesdaq market of Bursa Malaysia Securities Berhad. Hopematic specializes in R&D, marketing and commercialization of INS Bioscience Group’s healthcare products, supplying raw materials and developing bioscience technology product.

HOPEMATIC is rock-solidly committed in developing world-class herbal formulation through application of advance biotechnology processes.  HOPEMATIC capitalizes on its human capital and professionalism to commercialize the innovative and value-added products via international trading and providing OEM services both locally and overseas to countries in the ASEAN region, China, Europe, Australia, New Zealand, South Africa, Hong Kong and United States.

To develop and commercialize a novel biotech product, we forge strategic alliances between research institutions and pioneers in business sector. HOPEMATIC provides a platform for local and overseas research institutions to commercialize their research outputs. By partnering with scientists, researchers, and experts around the world, HOPEMATIC ensures that our products are of high standard; specially formulated and constantly evolving to meet the needs of our modern life.

HOPEMATIC has resources compliant to current Good Manufacturing Practices (cGMP) and ISO17025 standards. The core products ranged from home care, nutraceuticals to modern traditional herbal medicine and phytopharmaceuticals products. With our in-house R&D strength and joint collaborations, we have formulated many winning products that gained recognition worldwide. In the near future, HOPEMATIC aims to be the developer, manufacturer and distributor of pharmaceutical products that will contribute to a healthier society.